Stratification system for pharmaceutical care in cancer patients: Chinese expert consensus
This expert consensus establishes a standardized and practical framework for stratified pharmaceutical care in cancer patients, aiming to improve care quality, optimize resource allocation, and enhance patient outcomes in China. It may also serve as a reference model for international initiatives seeking to establish or refine standards for oncology pharmaceutical care.
Authors
- Lihong Shi (ORCID: https://orcid.org/0000-0001-8876-0802)
- Xue Ma (ORCID: https://orcid.org/0000-0001-7487-7882)
- Li Han (ORCID: https://orcid.org/0000-0002-4486-0534)
- Yan Chen (ORCID: https://orcid.org/0000-0003-1950-3903)
- Zhixi Liu (ORCID: https://orcid.org/0000-0002-2425-1168)
- Ya Chen (ORCID: https://orcid.org/0000-0002-1341-702X)
- Yu Zhang
- Mao Lin
- Zhiqiang Hu
- Hongtao Xiao
- Tingting Qi
- Suya Du
- Yue Qiu
- Junxiang Zhou
- Guohui Li
Institutions
- National Cancer Center (US)
- Sichuan Cancer Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-02-16
- DOI
- https://doi.org/10.3389/fphar.2025.1707229
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00